Clinical Trial: Topical Terbinafine Versus Hydrocortisone Combined With Oral Itraconazole for Seborrheic Dermatitis

U.S., Oct. 31 -- ClinicalTrials.gov registry received information related to the study (NCT07906886) titled 'Topical Terbinafine Versus Hydrocortisone Combined With Oral Itraconazole for Seborrheic Dermatitis' on Oct. 26.

Brief Summary: The goal of this clinical trial is to compare two creams used together with oral itraconazole in adults with moderate-to-severe seborrheic dermatitis. The main question it aims to answer is: does terbinafine 1% cream give lower disease severity than hydrocortisone 1% cream at the end of a 2-week course of oral itraconazole?

Participants took oral itraconazole 100 mg twice daily for 2 weeks and applied either terbinafine 1% cream or hydrocortisone 1% cream twice daily for 4 weeks. Disease severity (Seborrhe...